In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...

Healthcare providers, suppliers, compliance leaders, and private equity-backed platforms may prepare for increasing operational, ...

CMS launches its Medicare GLP-1 Bridge July 1, giving eligible Medicare Part D beneficiaries access to weight-loss GLP-1s at a $50 monthly copay through December 2027. For health systems and pharmacy ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.

Leading Republicans are looking toward the Government Accountability Office (GAO) to ensure CMS' new premium stabilization demonstration program is legal and in the best interest of seniors. In a ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Most opposition to the federal WISeR program focuses on delay in care. Not addressed is the economic and compassionate ...

Revisions to the US Centers for Medicare & Medicaid Services’ (CMS) competitive bidding programme (CBP) have been welcomed by the medtech industry, despite remaining concerns. The CMS has outlined ...

The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...

Unchecked MA expansion limits patient choice, access to care as health plans profit ...

The Medicare Shared Savings Program (MSSP) is a voluntary program in which healthcare professionals collaborate to provide better care to Medicare recipients while saving money. The MSSP rewards ...